Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PIWIL1 is a member of the PIWI subfamily of Argonaute proteins involved in RNA silencing, translational regulation, and stem cell self-renewal. It plays a central role in germline function by repressing transposable elements and is essential for spermatogenesis. In cancer, PIWIL1 acts as an oncogenic factor, promoting tumor cell proliferation, EMT, invasion, cancer stem-like properties, and chemoresistance through both piRNA-dependent and piRNA-independent mechanisms. Its overexpression correlates with poor prognosis in multiple tumors, making it a potential biomarker and therapeutic target.
Inhibition of PIWIL1 activity to suppress tumor cell proliferation, EMT, invasion, cancer stem-like properties, tumorigenesis, metastasis, and chemoresistance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Piwi-like protein 1 (PIWIL1).